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background: There are conflicting reports on the impact of moderate-severe mitral regurgitation (MR) on outcomes after transcatheter aortic 
valve replacement (TAVR). We perform a meta-analysis of available studies to evaluate the impact of moderate-severe MR on outcomes after TAVR.
methods: Mantel-Haenszel random effects model was used to calculate the risk ratio. Statistical analysis was performed using Review Manager 
5.1 statistics software.
results: Eight studies with a total of 6166 patients were identified. Moderate-severe MR was present in 24.2% (1491/6166) and none-mild 
MR was present in 75.8% (4684/6166) of patients undergoing TAVR. Moderate-severe MR was associated with a trend towards increased 30-day 
mortality (Risk ratio 1.35; 95% Confidence interval 0.95-1.93, p=0.10; Figure 1A). At 1 year post-TAVR, moderate-severe MR was associated with a 
statistically significant increase in mortality (Risk ratio 1.22; 95% Confidence interval 1.02-1.47, p=0.03; Figure 1B).
conclusion: Moderate or severe MR at baseline is common in patients undergoing TAVR and is associated with increased 1-year mortality.
 
